Vigil Neuroscience

Vigil Neuroscience is a biotechnology company focused on developing therapies for neurodegenerative diseases. They are committed to improving the lives of patients, caregivers, and families by restoring the vigilance of microglia, the brain's sentinel immune cells. Their approach centers on a precision medicine strategy, targeting genetically defined patient sub-populations with novel drug candidates designed to activate and restore microglial function. Their most advanced therapeutic programs focus on developing activators of TREM2, a microglial receptor protein whose dysfunction is linked to multiple neurodegenerative diseases.

Vigil Neuroscience is currently developing a pipeline of innovative microglial therapeutics across modalities of biologics and small molecules. Their lead clinical candidate, iluzanebart (VGL101), is a highly-targeted fully human monoclonal antibody directed against human TREM2 for the treatment of rare genetically defined microgliopathies, such as adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). They are also developing a novel, oral TREM2 agonist program for the treatment of more common neurodegenerative diseases like Alzheimer's disease (AD). Their commitment to patient advocacy is evident in their engagement with patient communities, caregivers, and advocacy groups.

Vigil Neuroscience does not explicitly state the types of job flexibility offered on their website or in their job postings. NONE.

Vigil Neuroscience offers a competitive benefits package that includes medical, dental, and vision insurance, a health savings account with employer contributions, a confidential employee assistance program, employer-paid life and disability insurance, a short and long-term disability program, telehealth services, a 401(k) retirement plan, fitness reimbursements, and pet insurance discounts.

Vigil Neuroscience is a microglia-focused therapeutics company dedicated to improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain’s immune system. Their mission is to harness the power of microglia to deliver transformative treatments for neurodegenerative diseases.

Vigil Neuroscience cultivates a collaborative and passionate work environment where employees are encouraged to be trailblazers and innovators, all while upholding the highest standards of ethics and integrity. The company prioritizes teamwork and support, recognizing the urgency to develop life-changing treatments for patients suffering from neurodegenerative diseases. They celebrate diversity and inclusion, creating a space where everyone feels valued and empowered to contribute their unique perspectives and talents.

Vigil Neuroscience celebrates inclusion and the unique and diverse contributions of each person regardless of their ethnicity, race, sex, gender identity and expression, national origin, age, languages spoken, veteran’s status, color, religion, disability, sexual orientation or any other protected category or belief system.